Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study
Rule, Simon, Barreto, Wolney Gois, Briones, Javier, Carella, Angelo M, Casasnovas, Olivier, Pocock, Chris, Wendtner, Clemens-Martin, Zaja, Francesco, Robson, Susan, MacGregor, Lachlan, Tschopp, Roger R, Nick, Sonja, Dreyling, Martin
Published in Haematologica (Roma) (01.02.2022)
Published in Haematologica (Roma) (01.02.2022)
Get full text
Journal Article
A strategy for preclinical formulation development using GastroPlus™ as pharmacokinetic simulation tool and a statistical screening design applied to a dog study
Kuentz, Martin, Nick, Sonja, Parrott, Neil, Röthlisberger, Dieter
Published in European journal of pharmaceutical sciences (2006)
Published in European journal of pharmaceutical sciences (2006)
Get full text
Journal Article
A Long‐Term Extension Study of Bevacizumab in Patients With Solid Tumors
Oza, Amit M., Dubois, François, Hegg, Roberto, Hernández, Carlos Alberto, Finocchiaro, Gaetano, Ghiringhelli, François, Zamagni, Claudio, Nick, Sonja, Irahara, Natsumi, Perretti, Thomas, Colombo, Nicoletta
Published in The oncologist (Dayton, Ohio) (01.12.2021)
Published in The oncologist (Dayton, Ohio) (01.12.2021)
Get full text
Journal Article
Bosutinib or Imatinib in Older Vs Younger Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Phase 3 BFORE Trial
Deininger, Michael W., Kota, Vamsi, Lipton, Jeff H., Milojkovic, Dragana, García Gutiérrez, Valentín, Leip, Eric, Nick, Sonja, Hochhaus, Andreas, Gambacorti-Passerini, Carlo, Cortes, Jorge E., Brummendorf, Tim H.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Long‐term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy
Cortes, Jorge E., Kantarjian, Hagop M., Mauro, Michael J., An, Fiona, Nick, Sonja, Leip, Eric, Gambacorti‐Passerini, Carlo, Brümmendorf, Tim H.
Published in European journal of haematology (01.06.2021)
Published in European journal of haematology (01.06.2021)
Get full text
Journal Article
Exploration of Potential Relationships between CD22 and Selected Safety Outcomes in the Inotuzumab Ozogamicin Phase 3 INO-VATE Study
Kebriaei, Partow, DeAngelo, Daniel J., Advani, Anjali S., O'Brien, Susan M., Marks, David, Kantarjian, Hagop M., Jabbour, Elias J., Wang, Tao, Vandendries, Erik, Laird, A. Douglas, Nick, Sonja, Stelljes, Matthias
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial
Wu, Xiaohua, Liu, Jihong, An, Ruifang, Yin, Rutie, Zhang, Yu, Zhou, Huaijun, He, Aiqin, Wang, Li, Zhang, Jieqing, Liu, Ziling, Duan, Wei, Zhu, Jianqing, Lou, Ge, Chen, Guilin, Cheng, Ying, Xue, Fengxia, Nick, Sonja, Wang, Haiyan, Li, Donghang
Published in Journal of gynecologic oncology (01.09.2024)
Published in Journal of gynecologic oncology (01.09.2024)
Get full text
Journal Article
A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study
KUENTZ, Martin, NICK, Sonja, PARROTT, Neil, RÖTHLISBERGER, Dieter
Published in European journal of pharmaceutical sciences (2005)
Get full text
Published in European journal of pharmaceutical sciences (2005)
Journal Article
Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 lambda6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide
HOFFMANN TORSTEN, WALDMEIER PIUS, NICK SONJA, SCHWITTER URS, HOFFMANN-EMERY FABIENNE
Year of Publication 09.01.2007
Get full text
Year of Publication 09.01.2007
Patent
Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 λ
Hoffmann, Torsten, Hoffmann-Emery, Fabienne, Nick, Sonja, Schwitter, Urs, Waldmeier, Pius
Year of Publication 09.01.2007
Get full text
Year of Publication 09.01.2007
Patent
Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide
HOFFMANN TORSTEN, WALDMEIER PIUS, NICK SONJA, SCHWITTER URS, HOFFMANN-EMERY FABIENNE
Year of Publication 23.09.2004
Get full text
Year of Publication 23.09.2004
Patent
Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide
Hoffmann-Emery, Fabienne, Hoffmann, Torsten, Nick, Sonja, Schwitter, Urs, Waldmeier, Pius
Year of Publication 23.09.2004
Get full text
Year of Publication 23.09.2004
Patent